C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2009
12/23/2009	CA2726281A1 Preparation and composition of inter-alpha inhibitor proteins from blood
12/23/2009	CA2724993A1 Plants having enhanced yield-related traits and a method for making the same
12/23/2009	CA2724900A1 Bifunctional molecules for inhibiting hiv entry
12/22/2009	US7635800 Yield-related polynucleotides and polypeptides in plants
12/22/2009	US7635798 Nucleic acid compositions conferring altered metabolic characteristics
12/22/2009	US7635767 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same
12/22/2009	US7635766 Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes
12/22/2009	US7635765 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin
12/22/2009	US7635763 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use
12/22/2009	US7635759 Gene encoding labyrinthin, a marker for cancer
12/22/2009	US7635758 Immunoglobulin for use in diagnosis of metabolic, glandular, cell proliferative, gastroitestinal amd reproductive disorders
12/22/2009	US7635757 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
12/22/2009	US7635755 Free of organic solvents and wherein fibroin solution is produced by process comprising dialyzing aqueous silk fibroin solution against hygroscopic polymer for sufficient time to result in aqueous fibroin solution of at least 10 wt %, wherein hygroscopic polymer has a molecular weight of 8,000 g/mol
12/22/2009	US7635754 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
12/22/2009	US7635753 Prostate cancer and melanoma antigens
12/22/2009	US7635752 Ablated SLAM-Dependent Entry
12/22/2009	US7635751 For development of pharmaceutical preparations such as neutral nerve function regulator, circulatory function regulator, a cardiac function regulator, an immune function regulator, a digestive organ function regulator, metabolic function regulator
12/22/2009	US7635750 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation
12/22/2009	US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds
12/22/2009	US7635688 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides
12/22/2009	US7635687 Vector system
12/22/2009	US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
12/22/2009	US7635679 A polypeptide variant of the human HMGB1 high affinity binding domain Box-A (HMGB1 Box-A); more favorable pharmacokinetic and pharmacodynamic profiles; diagnose, prevent, or treat pathologies associated with extracellular HMGB1 and associated with RAGE ( receptor for advanced glycation end products )
12/22/2009	US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/22/2009	US7635583 Protein crystal comprising the processivity clamp factor of DNA polymerase and a ligand, and its uses
12/22/2009	US7635576 CC-chemokine binding tick proteins
12/22/2009	US7635565 Analyzing blood type with identification of patient by genotyping
12/22/2009	US7635487 Nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. pneumoniae; for prevention and treatment of bacterial infections caused by Streptococcus pneumoniae
12/22/2009	US7635486 Where lipidation thereof is from expression of first nucleic acid sequence and protein portion thereof is from expression of second nucleic acid sequence and first and second sequences do not naturally occur together, such as a lipoprotein where first sequence encodes Borrelia lipoprotein, second, PsaA
12/22/2009	US7635485 Method of accelerated vaccination against Ebola viruses
12/22/2009	US7635484 Clostridial peptide for preventing or reducing immunoresistance to botulinum toxin therapy in humans and/or other mammals
12/22/2009	US7635483 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus
12/22/2009	US7635481 Ehrlichia canis bacterin, a carrier, an antibody response inducing agent and a cell-mediated immunity response inducing agent
12/22/2009	US7635480 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
12/22/2009	US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy
12/22/2009	US7635478 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/22/2009	US7635474 VEGF-binding fusion proteins
12/22/2009	US7635466 treating human cancers or tumors with biodrug; amino acid sequences; viricides; anticarcinogenic agent
12/22/2009	CA2492954C Pegylated t1249 polypeptide
12/22/2009	CA2451408C The production of soluble keratin derivatives
12/22/2009	CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/22/2009	CA2323607C Immunological methods to modulate myostatin in vertebrate subjects
12/22/2009	CA2279881C A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
12/22/2009	CA2232542C Novel polypeptides and polynucleotides relating to the .alpha.- and .beta.-subunits of glutamate dehydrogenases and methods of use
12/22/2009	CA2180309C Coccidiosis poultry vaccine
12/22/2009	CA2145761C Nucleic acid ligands and methods for producing the same
12/22/2009	CA2104871C Prad1 cyclin (cyclin d1) and its cdna
12/19/2009	CA2633246A1 Identification of therapeutic agents for hiv infection
12/17/2009	WO2009152519A2 Novel antiviral peptides against influenza virus
12/17/2009	WO2009152384A1 Solutions for tissue engineering and methods of use
12/17/2009	WO2009152364A2 Proteins that fluoresce at infrared wavelengths or generates singlet oxygen upon illumination
12/17/2009	WO2009152176A2 Recovery of insoluble enzyme from fermentation broth and formulation of insoluble enzyme
12/17/2009	WO2009152085A1 Novel bmp-12-related proteins and methods of their manufacture
12/17/2009	WO2009152023A1 Novel bacillus thuringiensis gene with lepidopteran activity
12/17/2009	WO2009151748A1 Novel bacillus thuringiensis gene with lepidopteran activity
12/17/2009	WO2009151708A2 Peptide analogs of alpha-melanocyte stimulating hormone
12/17/2009	WO2009151542A2 Nicotinic acid receptor ligands
12/17/2009	WO2009151491A2 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
12/17/2009	WO2009151337A2 Novel retinoid inducible factor and uses thereof
12/17/2009	WO2009151327A1 Block co-polypeptide and hydrogels made thereof
12/17/2009	WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2
12/17/2009	WO2009150888A1 Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent
12/17/2009	WO2009150865A1 Method for production of modified protein and modified protein produced by the method, and protein modification kit
12/17/2009	WO2009150835A1 Iqgap3 epitope peptides and vaccines containing the same
12/17/2009	WO2009150470A2 Suppression of cancers
12/17/2009	WO2009150469A2 Suppression of neuroendocrine diseases
12/17/2009	WO2009150419A1 Fructose biphosphate aldolase (fba) in neisseria
12/17/2009	WO2009150275A1 Human anti-dectin-1 antibody, hybridoma producing said antibody and applications thereof
12/17/2009	WO2009150215A2 Hybrid proteins comprising membrane receptor and ion channel, and their use as biosensors
12/17/2009	WO2009150146A1 Rift valley fever virus-like particles and their use for immunization and as test system
12/17/2009	WO2009149931A2 Fatty acid binding protein in the pathogenesis of cardiac dysfunction
12/17/2009	WO2009149910A1 Anti-angiogenic compositions and therapeutic applications thereof
12/17/2009	WO2009149562A1 Compositions and methods for modulating nicotinic/nmda receptor function
12/17/2009	WO2009149560A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
12/17/2009	WO2009149554A1 Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa)
12/17/2009	WO2009149493A1 Novel receptor hetero-dimers/-oligomers
12/17/2009	WO2009134917A3 Methods for treating inflammation
12/17/2009	WO2009125925A3 Growth factor-mimicking peptides and uses thereof
12/17/2009	WO2009122441A3 Method of cloning stable stress tolerant superoxide dismutase using degenerate primers
12/17/2009	WO2009120993A3 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof
12/17/2009	WO2009118710A3 Cd4-related polypeptides and methods of use
12/17/2009	WO2009109532A3 Use of defensins against tuberculosis
12/17/2009	WO2009106532A3 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents
12/17/2009	WO2009102509A9 Vaccines and diagnostics for ehrlichia chaffeensis
12/17/2009	WO2009101181A3 Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells
12/17/2009	WO2009100934A9 Identification of a novel cysteine-rich cell penetrating peptide
12/17/2009	WO2009087424A3 Proteinaceous compounds
12/17/2009	WO2009074861A3 Improved vaccine
12/17/2009	WO2009071460A3 New non-selective somatostatin analogues
12/17/2009	WO2008030282A3 Recombinant vaccine against bluetongue virus
12/17/2009	US20090313726 Abiotic stress tolerant gene from avicennia marina encoding a protein
12/17/2009	US20090313725 Gibberellin 2-Oxidase Genes And Uses Thereof
12/17/2009	US20090313724 Alteration of Flowering Time in Plants
12/17/2009	US20090313723 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
12/17/2009	US20090313722 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
12/17/2009	US20090313721 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
12/17/2009	US20090313711 Novel protein and production process and use thereof
12/17/2009	US20090312528 Method of Producing a Set of MHC Molecules
12/17/2009	US20090312525 Isolated aquaporin in its closed conformation
12/17/2009	US20090312524 Compositions and methods comprising collagen

1 ... 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 ... 2916